Adage Capital Partners
TENX icon

Adage Capital Partners’s Tenax Therapeutics TENX Stock Holding History

Adage Capital Partners’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.86M Hold
540,126
– – 0.01% 757
2026
Q1 		$8.64M Buy
540,126
+456,793
+548% +$6.18M 0.01% 720
2025
Q4 		$1.02M Hold
83,333
– – ﹤0.01% 854
2025
Q3 		$634K Hold
83,333
– – ﹤0.01% 841
2025
Q2 		$480K Hold
83,333
– – ﹤0.01% 810
2025
Q1 		$546K Hold
83,333
– – ﹤0.01% 810
2024
Q4 		$516K Hold
83,333
– – ﹤0.01% 839
2024
Q3 		$288K Buy
+83,333
New +$302K ﹤0.01% 824

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Adage Capital Partners's TENX Position: Q2 2026 in Review

Adage Capital Partners held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 540,126 shares worth $7.86M. The position accounts for 0.01% of the portfolio, ranked #757.

Adage Capital Partners first reported a position in TENX in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.64M in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Adage Capital Partners held 540,126 shares of Tenax Therapeutics worth $7.86M as of Q2 2026.
  • Adage Capital Partners left its Tenax Therapeutics share count unchanged in Q2 2026.
  • Tenax Therapeutics made up 0.01% of Adage Capital Partners's portfolio in Q2 2026, its #757 holding.
  • Adage Capital Partners first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Adage Capital Partners's Tenax Therapeutics position peaked at $8.64M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.